Publication Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Yang D, Chen J, Shi C, et al. Inflammation. 2014; 37 (2) : 593-8.
Publication An in vitro model of Mycobacterium leprae induced granuloma formation. Wang H, Maeda Y, Fukutomi Y, et al. BMC infectious diseases. 2013; Download PDF
Publication Toll-like receptor 1 N248S single-nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection. Marques CS, Brito-de-Souza VN, Guerreiro LTA, et al. The Journal of infectious diseases. 2013; 208 (1) : 120-9.
Publication Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy. Duthie MS, Sampaio LH, Oliveira RM, et al. Vaccine. 2013; 31 (5) : 813-9.
Publication Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy. Saini C, Prasad H K, Rani R, et al. Clinical and vaccine immunology : CVI. 2013; 20 (5) : 673-82.
Publication Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy. Palermo ML, Pagliari C, Trindade MÂB, et al. American Society of Tropical Medicine and Hygiene. The American journal of tropical medicine and hygiene. 2012; 86 (5) : 878-83.
Publication Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy. Chaduvula M, Murtaza A, Misra N, et al. American Society For Microbiology. Infection and immunity. 2012; 80 (2) : 742-52.
Publication Seagrass as a potential source of natural antioxidant and anti-inflammatory agents. Yuvaraj N, Kanmani P, Satishkumar R, et al. Informa Healthcare. Pharmaceutical biology. 2012; 50 (4) : 458-67.
Publication Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10. Mazzoccoli L, Cadoso SH, Amarante GW, et al. Masson Pub. USA, Inc. . Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2012; 66 (5) : 323-9.
Publication Interleukin-10-dependent down-regulation of interferon-gamma response to Leishmania by Mycobacterium leprae antigens during the clinical course of a coinfection. Azeredo-Coutinho R B G, Matos D C S, Nery J A C, et al. Scielo. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2012; 45 (7) : 632-6. Download PDF
Publication BCG-mediated protection against Mycobacterium ulcerans infection in the mouse. Converse PJ, Almeida DV, Nuermberger EL, et al. PLoS neglected tropical diseases. 2011; 5 (3) : e985. Download PDF
Publication The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Souza Sales J, Lara F A, Amadeu T P, et al. Clinical and experimental immunology. 2011; 165 (2) : 251-63.
Publication Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. Mattos KA, D'Avila H, Rodrigues LS, et al. Journal of leukocyte biology. 2010; 87 (3) : 371-84.
Publication Abnormalities in intracellular processing and expression of interferon-gamma receptor in adherent cells from lepromatous leprosy patients. Guerrero-Velázquez C, Lopez-Roa RI, Delgado-Rizo V, et al. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2010; 30 (2) : 99-105.
Publication Presence of intestinal helminths decreases T helper type 1 responses in tuberculoid leprosy patients and may increase the risk for multi-bacillary leprosy. Diniz L M, Magalhães E F L, Pereira F E L, et al. Clinical and experimental immunology. 2010; 161 (1) : 142-50. Download PDF
Publication Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. PEREIRA A C, Brito-de-Souza V N, Cardoso C C, et al. Genes and immunity. 2009; 10 (2) : 174-80.
Publication Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. Zelazny AM, Ding L, Elloumi HZ, et al. Infection and immunity. 2009; 77 (10) : 4337-44.
Publication Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18. Lopez Roa RI, Guerrero Velásquez C, Alvarado Navarro A, et al. International immunopharmacology. 2008; 8 (13-14) : 1715-20.
Publication Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide. Shannon E, Noveck R, Sandoval F, et al. Immunopharmacology and immunotoxicology. 2008; 30 (3) : 447-57.
Publication Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states. Santos D O, Castro H C, Bourguignon S C, et al. Clinical and experimental dermatology. 2007; 32 (1) : 75-80.
